CD8A and neoplasm: In conclusion, we show that protective thresholds upon immunization with MCMV vectors can be sharply defined via determination of tumor-specific CD8 T cells in blood, and that the inoculum dosage and route of infection are crucial elements determining the magnitude of these cells.